During the past decade, Shanghai East Hospital conducted 141 clinical trials. In the 10-year time frame, 141 clinical trials started and 7 clinical trials were completed, i.e. on average, 5% percent of trials that started reached the finish line to date. In the past 5 years, 105 clinical trials started and 6 clinical trials were completed. i.e. 5.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shanghai East Hospital" #1 sponsor was "Shanghai East Hospital" with 14 trials, followed by "Janssen Research & Development, LLC" with 8 trials sponsored, "Takeda" with 5 trials sponsored, "I-Mab Biopharma Co. Ltd." with 4 trials sponsored and "Merck Sharp & Dohme LLC" with 4 trials sponsored. Other sponsors include 106 different institutions and companies that sponsored additional 89 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shanghai East Hospital" #1 collaborator was "Shanghai East Hospital" with 8 trials as a collaborator, "Covance" with 2 trials as a collaborator, "Eisai Inc." with 2 trials as a collaborator, "Nanjing Legend Biotech Co." with 2 trials as a collaborator and "Regend Therapeutics" with 2 trials as a collaborator. Other collaborators include 47 different institutions and companies that were collaborators in the rest 56 trials.

According to Clinical.Site data, the most researched conditions in "Shanghai East Hospital" are "Advanced Solid Tumor" (13 trials), "Solid Tumor" (10 trials), "Gastric Cancer" (6 trials), "Advanced Solid Tumors" (4 trials) and "Head and Neck Squamous Cell Carcinoma" (4 trials). Many other conditions were trialed in "Shanghai East Hospital" in a lesser frequency.

Most popular intervention types in "Shanghai East Hospital" are "Drug" (119 trials), "Biological" (20 trials), "Procedure" (5 trials), "Device" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Carboplatin" (6 trials), "Cisplatin" (6 trials), "Oxaliplatin" (6 trials) and "Capecitabine" (5 trials). Other intervention names were less common.

The vast majority of trials in "Shanghai East Hospital" are 144 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are 82 active trials in "Shanghai East Hospital". 4 are not yet recruiting, 57 are recruiting, 19 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 29 completed trials in Shanghai East Hospital, 2 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Shanghai East Hospital, 64 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 11 trials that are defined as “Not Applicable".